ERD

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

01-09-2024

-

31-08-2029

Show more information

Organisation HUMANITAS MIRASOLE SPA

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

01-01-2023

-

31-12-2027

Show more information

Organisation HUMANITAS MIRASOLE SPA

SYNTHIA | Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

01-09-2024

-

31-08-2029

Show more information

Organisation HUMANITAS MIRASOLE SPA

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

01-01-2020

-

31-12-2024

Show more information

Organisation HUMANITAS MIRASOLE SPA

GenoMed4ALL | Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

01-01-2021

-

31-12-2024

Show more information

Organisation HUMANITAS MIRASOLE SPA

Algae4IBD | ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

01-06-2021

-

31-05-2025

Show more information

Organisation HUMANITAS MIRASOLE SPA

HARMONIA | Development of a Support System for Improved Resilience and Sustainable Urban areas to cope with Climate Change and Extreme Events based on GEOSS and Advanced Modelling Tools

01-06-2021

-

31-01-2025

Show more information

Organisation HUMANITAS MIRASOLE SPA

OperA | OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

01-09-2022

-

31-08-2027

Show more information

Organisation HUMANITAS MIRASOLE SPA

SYNTHEMA | Synthetic generation of hematological data over federated computing frameworks

01-12-2022

-

30-11-2026

Show more information

Organisation HUMANITAS MIRASOLE SPA

PREMIO COLLAB | Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer

01-01-2024

-

31-12-2029

Show more information

Organisation HUMANITAS MIRASOLE SPA

NEUROCOV | The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV

01-09-2022

-

31-08-2027

Show more information

Organisation HUMANITAS MIRASOLE SPA

MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

01-09-2015

-

30-09-2021

Show more information

Organisation HUMANITAS MIRASOLE SPA

COVID-X | COVID eXponential Programme

01-11-2020

-

31-10-2022

Show more information

Organisation HUMANITAS MIRASOLE SPA

TRAIN-HEART | TRAIN-HEART

01-06-2019

-

31-08-2023

Show more information

Organisation HUMANITAS MIRASOLE SPA

EDEN2020 | Enhanced Delivery Ecosystem for Neurosurgery in 2020

01-04-2016

-

30-09-2021

Show more information

Organisation HUMANITAS MIRASOLE SPA

FIBROTARGET | Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

01-04-2023

-

31-03-2028

Show more information

Organisation HUMANITAS MIRASOLE SPA

SQUEEZE | Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

01-12-2022

-

30-11-2027

Show more information

Organisation HUMANITAS MIRASOLE SPA

LION-HEARTED | Light and Organic Nanotechnology for Cardiovascular Disease

01-05-2019

-

31-10-2023

Show more information

Organisation HUMANITAS MIRASOLE SPA

TUDCA-ALS | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)

01-01-2018

-

31-12-2023

Show more information

Organisation HUMANITAS MIRASOLE SPA

ESA -ITN | European Sepsis Academy: towards new biomarkers to improve sepsis management

01-03-2016

-

29-02-2020

Show more information

Organisation HUMANITAS MIRASOLE SPA

BIORECAR | Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues

01-07-2018

-

31-12-2024

Show more information

Organisation HUMANITAS MIRASOLE SPA

PHII | PTX3 in Humoral Innate Immunity

01-09-2015

-

31-08-2020

Show more information

Organisation HUMANITAS MIRASOLE SPA

PERSYST | Generation and maintenance of long-lived memory T cells in humans

01-09-2015

-

31-05-2021

Show more information

Organisation HUMANITAS MIRASOLE SPA

MATILDA | Microglia As conTroller of braIn metaboLism During Aging

01-01-2023

-

31-12-2027

Show more information

Organisation HUMANITAS MIRASOLE SPA

miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy

01-12-2016

-

31-05-2018

Show more information

Organisation HUMANITAS MIRASOLE SPA

DaPhNIs | Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development

16-07-2019

-

15-07-2021

Show more information

Organisation HUMANITAS MIRASOLE SPA

MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer

01-01-2017

-

31-12-2018

Show more information

Organisation HUMANITAS MIRASOLE SPA

NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

20-05-2015

-

19-05-2017

Show more information

Organisation HUMANITAS MIRASOLE SPA

Pituitary enhancers | Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology

16-03-2020

-

15-03-2022

Show more information

Organisation HUMANITAS MIRASOLE SPA

SUMO-PCDH10 | Physiological consequences of Protocadherin-10 sumoylation on neuronal function.

01-06-2019

-

31-08-2021

Show more information

Organisation HUMANITAS MIRASOLE SPA

Projects overview

Selected filters:

CarrerasPathfinders | Enabling the next generation in search of blood cancer cures

CarrerasLeaders | Carreras Postdoc Program Empowering Future Leaders to Fight Blood Cancers

SYNTHIA | Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

ImmUniverse | Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies

GenoMed4ALL | Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

Algae4IBD | ALGAE4IBD –FROM NATURE TO BEDSIDE- ALGAE BASED BIO COMPOUND FOR PREVENTION AND TREATMENT OF INFLAMMATION, PAIN AND IBD

HARMONIA | Development of a Support System for Improved Resilience and Sustainable Urban areas to cope with Climate Change and Extreme Events based on GEOSS and Advanced Modelling Tools

OperA | OPTIMISING COLORECTAL CANCER PREVENTION TROUGH PERSONALISED TREATMENT WITH ARTIFICIAL INTELLIGENCE

SYNTHEMA | Synthetic generation of hematological data over federated computing frameworks

PREMIO COLLAB | Personalised response monitoring in oncology: co-creating clinical trials in advanced breast cancer

NEUROCOV | The pandemic within: tackling brain vulnerability in COVID19 at high resolution: NEUROCOV

MIROCALS | Efficacy and safety of low-dose IL-2 (ld-IL-2) as a Treg enhancer for anti-neuroinflammatory therapy in newly diagnosed Amyotrophic Lateral Sclerosis (ALS) patients

COVID-X | COVID eXponential Programme

TRAIN-HEART | TRAIN-HEART

EDEN2020 | Enhanced Delivery Ecosystem for Neurosurgery in 2020

FIBROTARGET | Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases

SQUEEZE | Maximising Impact of Prescription Drugs in Rheumatoid Arthritis

LION-HEARTED | Light and Organic Nanotechnology for Cardiovascular Disease

TUDCA-ALS | Safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS)

ESA -ITN | European Sepsis Academy: towards new biomarkers to improve sepsis management

BIORECAR | Direct cell reprogramming therapy in myocardial regeneration through an engineered multifunctional platform integrating biochemical instructive cues

PHII | PTX3 in Humoral Innate Immunity

PERSYST | Generation and maintenance of long-lived memory T cells in humans

MATILDA | Microglia As conTroller of braIn metaboLism During Aging

miRCaP | Innovative nanoparticle formulation for a miR-133 based treatment of cardiac hypertrophy

DaPhNIs | Role of the Maternal Gut Microbiota in Immune Activation at the Maternal-Foetal Interface: Impact on Preeclampsia and Offspring's Immune Development

MONONANOCHEM | In vivo engineering of monocytes loaded with nano-chemotherapeutic formulations: a novel live-cell mediated drug delivery system for the treatment of cancer

NANOTAM | Development and Evaluation of Nanomedicines for Cancer Treatment through Immunomodulation: Targeting Tumor-Associated Macrophages

Pituitary enhancers | Identification and functional validation of novel enhancer sequences involved in pituitary gland development and pathology

SUMO-PCDH10 | Physiological consequences of Protocadherin-10 sumoylation on neuronal function.